N-Dihydrogalactochitosan Drives Conventional and Alternative Activations of STING to Synergize Type I IFN and IL-1β Productions for Antitumor Immunity.
Hoover AR, Liu K, Furrer C, Lam SSK, Anderson DW, Zhou Z, Yang J, Wong CF, Medcalf AD, Sun XH, Hode T, Alleruzzo L, Delawder A, Raker J, Abousleiman G, Valerio TI, Sun Y, Papin JF, Li M, Chen WR.
Hoover AR, et al. Among authors: valerio ti.
Adv Funct Mater. 2024 Dec 16;34(51):2410079. doi: 10.1002/adfm.202410079. Epub 2024 Sep 9.
Adv Funct Mater. 2024.
PMID: 39896882